Literature DB >> 19528468

Molecular mechanisms of sequence-dependent antitumor effects of SN-38 and 5-fluorouracil combination therapy against colon cancer cells.

Shoujiro Torigoe1, Yutaka Ogata, Keiko Matono, Kazuo Shirouzu.   

Abstract

BACKGROUND: The aim of this study was to clarify the molecular mechanisms of the sequence-dependent antitumor activity of SN-38 and 5-fluorouracil (5-FU) against colon cancer cells.
MATERIALS AND METHODS: KM12SM and HCT116 colon cancer cells were exposed to 5-FU and/or SN-38 in various conditions. The nature of interactions was determined by median-effect analysis. Cell cycle, apoptosis, and expression of thymidylate synthase (TS) were analyzed.
RESULTS: A strong synergism was observed after initial sequential exposure of SN-38, and the activity was enhanced by a 24 h-interval to the drug-exposure. Antagonism was observed after low-dosage initial sequential exposure of 5-FU. Low-dosage 5-FU caused G(2) arrest and high-dosage 5-FU caused G(1) arrest. TS protein level significantly decreased after exposure to SN-38.
CONCLUSION: The sequence dependency between SN-38 and 5-FU against colon cancer cells may be related to the dual action on cell cycle regulation by 5-FU and to the down-regulation of TS level by SN-38.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19528468

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Combined efficacy and mechanism of trifluridine and SN-38 in a 5-FU-resistant human colorectal cancer cell lines.

Authors:  Kazuaki Matsuoka; Teiji Takechi
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

2.  Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer.

Authors:  Junli Ma; Yan Zhang; Hong Shen; Linda Kapesa; Wenqiang Liu; Mengsi Zeng; Shan Zeng
Journal:  Tumour Biol       Date:  2015-07-05

3.  Gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line.

Authors:  Isabella Palumbo; Simonetta Piattoni; Vincenzo Valentini; Valeria Marini; Paola Contavalli; Monica Calzuola; Fabio Maria Vecchio; Debora Cecchini; Franca Falzetti; Cynthia Aristei
Journal:  Int J Colorectal Dis       Date:  2013-08-06       Impact factor: 2.571

4.  Multicenter Phase II Study of a New Effective S-1 and Irinotecan Combination Schedule in Patients with Unresectable Metastatic or Recurrent Colorectal Cancer.

Authors:  Yutaka Ogata; Takaho Tanaka; Yoshito Akagi; Nobuya Ishibashi; Yoshiaki Tsuji; Keiko Matono; Makoto Isobe; Susumu Sueyoshi; Atsushi Kaibara; Kazuo Shirouzu
Journal:  Clin Med Insights Oncol       Date:  2013-02-10

5.  Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancers.

Authors:  Laura W Goff; Nilay Thakkar; Liping Du; Emily Chan; Benjamin R Tan; Dana B Cardin; Howard L McLeod; Jordan D Berlin; Barbara Zehnbauer; Chloe Fournier; Joel Picus; Andrea Wang-Gillam; Wooin Lee; A Craig Lockhart
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.